Home / Nervous system / Tafamidis
ATC N07XX08 · Other Nervous System Drugs · updated 2 Nov 2026
Tafamidis shortage
As of 2 Nov 2026, Tafamidis has a reported shortage in 1 of the 16 countries we track (Sweden), covering 1 product from 1 company.
Is there a Tafamidis shortage?
Yes. As of 2 Nov 2026, Tafamidis is reported short in 1 of the 16 countries we track: Sweden. The earliest expected return is 23 Dec 2026 (Sweden).
Which companies are short
products short, all countriesListed: Pfizer PFE · NYSE
Compared with similar medicines
ATC group N07XX · Other Nervous System DrugsAffected products
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| SE | Vyndaqel 61 mg Blister, 30 x 1 kapslar (endos) anticipated | Pfizer Europe MA EEIG | 7 Dec 2026 | 23 Dec 2026 | Not stated |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.
Questions
Is there a Tafamidis shortage?
Yes. As of 2 Nov 2026, Tafamidis is reported short in 1 of the 16 countries we track: Sweden. The earliest expected return is 23 Dec 2026 (Sweden).
When will Tafamidis be back in stock?
Companies expect supply back from 23 Dec 2026 in Sweden; Sweden: 23 Dec 2026. These are company estimates reported to each authority.
Why is Tafamidis in short supply?
The most common reason reported is: not stated. Reasons by product are listed in the table below.
Which companies have Tafamidis shortages?
Pfizer.